RT Journal Article
SR Electronic
T1 Immunostimulation in cancer therapy
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 73
OP 74
DO 10.1136/dtb.15.19.73
VO 15
IS 19
YR 1977
UL http://dtb.bmj.com/content/15/19/73.abstract
AB Patients with advanced cancer often show evidence of impaired immunological defences which could be made worse by most of the commonly used anti-cancer drugs. However some patients have intact immunological defences and in the case of some lymphomas this is reflected in a better prognosis. Recently drugs have been used in cancer in an attempt to stimulate the patient’s own defences against his disease.